First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors
Condition(s):Advanced Solid TumorLast Updated:December 28, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumorLast Updated:December 28, 2022Recruiting
Condition(s):PainLast Updated:December 12, 2018Completed
Condition(s):Rheumatoid ArthritisLast Updated:December 11, 2020Completed
Condition(s):Uterine Cervical NeoplasmsLast Updated:June 7, 2022Not yet recruiting
Condition(s):Atherosclerosis Coronary Artery With Angina Pectoris; Atheroscleroses, Coronary; Atherosclerotic Plaque; Thin-cap fIbroatheroma; AtherosclerosisLast Updated:August 24, 2022Active, not recruiting
Condition(s):Acute Heart FailureLast Updated:May 6, 2021Completed
Condition(s):StrokeLast Updated:October 6, 2022Completed
Condition(s):Hearing LossLast Updated:April 12, 2018Completed
Condition(s):Healthy VolunteersLast Updated:January 6, 2023Completed
Condition(s):Metastatic Solid TumorsLast Updated:January 6, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.